Q32 Bio Inc.
QTTB
$15.15
-$0.22-1.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.57% | -113.18% | 881.30% | 22.13% | 13.98% |
| Total Depreciation and Amortization | -5.56% | 0.00% | -1.10% | 0.00% | -23.53% |
| Total Amortization of Deferred Charges | -200.00% | -10.81% | -19.57% | 195.83% | -200.00% |
| Total Other Non-Cash Items | 14.85% | 102.68% | -4,886.13% | -36.66% | 246.95% |
| Change in Net Operating Assets | 778.52% | -198.95% | -111.26% | 150.98% | -48.81% |
| Cash from Operations | 51.52% | -2.64% | -46.10% | 60.29% | 14.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -428.34% | -0.06% | 0.06% | -- | -- |
| Issuance of Common Stock | 545.29% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 566.07% | 663.19% | 0.06% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,162.39% | 430.73% | 87.19% | 45.61% | 14.67% |